Clinical Trials at NEXT Dallas
As of August 2026, 19 paid clinical trials are recruiting at NEXT Dallas, located at 1845 E NORTHGATE DR, HAGGAR BLDG 2ND FLOOR, IRVING, TX 75062-4736, phone (972) 721-5322 in Irving, Texas. Active studies at this site cover conditions such as Advanced Solid Tumors, Advanced Solid Tumor and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
19 clinical trials at NEXT Dallas
·Clear filters·A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
A Study of HS-20110 in Participants With Advanced Solid Tumors
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Common conditions studied in Irving
- Advanced Solid Tumors (10 active studies)
- Advanced Solid Tumor (7 active studies)
- Colorectal Cancer (7 active studies)
- Breast Cancer (5 active studies)
- Solid Tumor (5 active studies)
- Cancer (4 active studies)
Leading research sponsors in Irving
- Pfizer
- Amgen
- AstraZeneca
- Revolution Medicines, Inc.
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Irving?
There are approximately 118 recruiting clinical trials in Irving, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Irving pay participants?
Most recruiting trials in Irving compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Irving?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Irving?
The most common conditions under active study in Irving include Advanced Solid Tumors (10), Advanced Solid Tumor (7), Colorectal Cancer (7), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Irving?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Irving on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Irving?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Irving?
Recruiting research sites in Irving include NEXT Dallas, NEXT Oncology, NEXT Oncology Dallas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Irving right now?
The largest active categories in Irving are Cancer & tumors (58), Diabetes & metabolic (5), Mental health & behavior (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of NEXT Dallas?
NEXT Dallas is located at 1845 E NORTHGATE DR, HAGGAR BLDG 2ND FLOOR, IRVING, TX 75062-4736. Use the Google Maps link in the intro above to get directions.
How do I contact NEXT Dallas?
You can reach NEXT Dallas by phone at (972) 721-5322. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.